Stockholm - Delayed Quote SEK

Moberg Pharma AB (publ) (MOB.ST)

Compare
9.55
-0.22
(-2.25%)
At close: January 24 at 5:29:40 PM GMT+1

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

33.8

Severe

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
ISOFOL.ST Isofol Medical AB 34 -- -- --
NEU.XA NEUREN FPO NZ [NEU] 34 -- -- --
MOB.ST Moberg Pharma AB 34 -- -- --
PHXM.PA PHAXIAM THERAPEUTICS 34 -- -- --
AMLX Amylyx Pharmaceuticals, Inc. 34 -- -- --

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 1/2025
MOB.ST
Category Average
N/A None Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No

Related Tickers